A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Clinical trial NCT07000123 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07000123
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2025-05-28
Primary completion: 2027-01-11
Enrollment: 3103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.